MEP18308A - Benzothiophenes, formulations containing same, and methods - Google Patents

Benzothiophenes, formulations containing same, and methods

Info

Publication number
MEP18308A
MEP18308A MEP-183/08A MEP18308A MEP18308A ME P18308 A MEP18308 A ME P18308A ME P18308 A MEP18308 A ME P18308A ME P18308 A MEP18308 A ME P18308A
Authority
ME
Montenegro
Prior art keywords
compounds
benzothiophenes
methods
formulations containing
containing same
Prior art date
Application number
MEP-183/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Gordon N Arbuthnot
Brian W Dalder
Kerry J Hartauer
Wayne D Luke
Robert E Stratford Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP18308(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9607110.5A external-priority patent/GB9607110D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MEP18308A publication Critical patent/MEP18308A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thin Film Transistor (AREA)
MEP-183/08A 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods MEP18308A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1416796P 1996-03-26 1996-03-26
GBGB9607110.5A GB9607110D0 (en) 1996-04-04 1996-04-04 Benzothiopenes formulations containing same and methods
PCT/US1997/004259 WO1997035571A1 (en) 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods
YUP41898 1998-09-25

Publications (1)

Publication Number Publication Date
MEP18308A true MEP18308A (en) 2010-06-10

Family

ID=26309061

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-183/08A MEP18308A (en) 1996-03-26 1997-03-20 Benzothiophenes, formulations containing same, and methods
MEP-2008-183A ME00074B (me) 1996-03-26 1997-03-20 Benzotiofeni, formulacije koje ih sadrže i proizvod

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-183A ME00074B (me) 1996-03-26 1997-03-20 Benzotiofeni, formulacije koje ih sadrže i proizvod

Country Status (29)

Country Link
EP (2) EP0910369B1 (cs)
JP (5) JP2000507268A (cs)
CN (1) CN1162153C (cs)
AR (1) AR006387A1 (cs)
AT (1) ATE464897T1 (cs)
AU (1) AU723797B2 (cs)
BR (1) BR9708248A (cs)
CA (1) CA2250191C (cs)
CO (1) CO4780022A1 (cs)
CZ (1) CZ300341B6 (cs)
DE (1) DE69739855D1 (cs)
DK (1) DK0910369T3 (cs)
EA (1) EA001257B1 (cs)
ES (1) ES2341399T3 (cs)
ID (1) ID19813A (cs)
IL (2) IL126320A (cs)
ME (2) MEP18308A (cs)
MY (1) MY115533A (cs)
NO (1) NO320894B1 (cs)
NZ (1) NZ332036A (cs)
PL (1) PL191148B1 (cs)
PT (1) PT910369E (cs)
RO (1) RO121117B1 (cs)
SI (1) SI0910369T1 (cs)
TR (1) TR199801915T2 (cs)
TW (1) TW513421B (cs)
UA (1) UA57596C2 (cs)
WO (1) WO1997035571A1 (cs)
YU (1) YU41898A (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE464897T1 (de) * 1996-03-26 2010-05-15 Lilly Co Eli Benzothiophene und denen enthaltende zusammensetzungen
CZ341297A3 (cs) * 1996-10-30 1998-05-13 Eli Lilly And Company Způsob zlepšení léčby nebo profylaxe rakoviny prsu
ZA979720B (en) 1996-10-30 1999-04-29 Lilly Co Eli Prophylaxis of breast cancer
EP1832582A1 (en) * 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
GB2456096B (en) 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
WO2009080364A1 (en) * 2007-12-21 2009-07-02 Synthon B.V. Raloxifene composition
TWI440633B (zh) * 2008-04-15 2014-06-11 Nippon Chemiphar Co Activator of Activated Receptors for Peroxisome Producers
SI2373305T1 (sl) * 2008-12-11 2017-09-29 Besins Healthcare Luxembourg Sarl Transdermalni farmacevtski sestavki, ki obsegajo serm
EP2448562B1 (en) 2009-07-02 2013-11-06 Synthon B.V. Raloxifene composition
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
GB201515387D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
GB201515391D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
PL3251661T3 (pl) 2016-05-30 2021-06-14 Sun Pharmaceutical Industries Limited Kompozycja raloksyfenu do posypywania

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
JPS63112519A (ja) * 1986-10-28 1988-05-17 Shin Etsu Chem Co Ltd ニフエジピン製剤の製造方法
NL9000634A (nl) * 1990-03-20 1991-10-16 Catharina Ziekenhuis Stichting Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
KR100294525B1 (ko) * 1992-10-09 2001-09-17 후루타 다케시 미세한조립체의제조방법
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
CA2176130A1 (en) * 1993-12-21 1995-06-29 Thomas Alan Crowell Non-peptide tachykinin receptor antagonists
ZA951497B (en) * 1994-03-02 1996-08-23 Lilly Co Eli Orally administerable pharmaceutical formulations
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6723739B1 (en) * 1994-05-20 2004-04-20 Eli Lilly And Company Glucopyranoside benzothiophenes
US5494920A (en) 1994-08-22 1996-02-27 Eli Lilly And Company Methods of inhibiting viral replication
CO4410190A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5494929A (en) 1995-01-12 1996-02-27 Eli Lilly And Company Methods of inhibiting growth hormone effects
US5532254A (en) * 1995-06-07 1996-07-02 Eli Lilly And Company Modulation of calcium channels using benzothiophenes
ATE464897T1 (de) * 1996-03-26 2010-05-15 Lilly Co Eli Benzothiophene und denen enthaltende zusammensetzungen

Also Published As

Publication number Publication date
CZ305398A3 (cs) 1999-05-12
UA57596C2 (uk) 2003-06-16
ID19813A (id) 1998-08-06
WO1997035571A1 (en) 1997-10-02
JP2016106159A (ja) 2016-06-16
JP2009019057A (ja) 2009-01-29
SI0910369T1 (sl) 2010-08-31
PL329051A1 (en) 1999-03-01
EP0910369B1 (en) 2010-04-21
AU723797B2 (en) 2000-09-07
ES2341399T3 (es) 2010-06-18
JP6095725B2 (ja) 2017-03-15
IL140742A0 (en) 2002-02-10
IL126320A0 (en) 1999-05-09
CA2250191C (en) 2005-11-15
AU2215497A (en) 1997-10-17
CA2250191A1 (en) 1997-10-02
EP2266560A1 (en) 2010-12-29
ATE464897T1 (de) 2010-05-15
BR9708248A (pt) 1999-07-27
EA199800865A1 (ru) 1999-02-25
NO320894B1 (no) 2006-02-06
RO121117B1 (ro) 2006-12-29
MY115533A (en) 2003-07-31
CO4780022A1 (es) 1999-05-26
CZ300341B6 (cs) 2009-04-22
TW513421B (en) 2002-12-11
EP0910369A4 (en) 2001-03-21
HK1020671A1 (en) 2000-05-19
NO984444D0 (no) 1998-09-24
JP6095821B2 (ja) 2017-03-15
IL126320A (en) 2001-08-08
YU41898A (sh) 1999-07-28
CN1213967A (zh) 1999-04-14
AR006387A1 (es) 1999-08-25
PT910369E (pt) 2010-06-04
TR199801915T2 (xx) 1998-12-21
JP2013166797A (ja) 2013-08-29
NZ332036A (en) 1999-04-29
EA001257B1 (ru) 2000-12-25
PL191148B1 (pl) 2006-03-31
DK0910369T3 (da) 2010-07-26
EP0910369A1 (en) 1999-04-28
JP2015157865A (ja) 2015-09-03
NO984444L (no) 1998-11-26
DE69739855D1 (de) 2010-06-02
JP2000507268A (ja) 2000-06-13
IL140742A (en) 2012-02-29
CN1162153C (zh) 2004-08-18
ME00074B (me) 2010-10-10

Similar Documents

Publication Publication Date Title
MEP18308A (en) Benzothiophenes, formulations containing same, and methods
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
TW240215B (cs)
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
SE8700498D0 (sv) Novel pharmaceologically active compounds
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
MY104535A (en) Oral composition for the treatment of inflammatory bowel diseases.
NZ192196A (en) 1-phenyl-2-azolyl-ethanols pharmaceutical compositions
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
IL98262A (en) Chromone derivatives and pharmaceutical compositions containing them
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
IL93165A0 (en) Phenylhydrazones,their preparation and pharmaceutical compositions containing them
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
EP0758312A4 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
NZ212614A (en) Acetylenic phenoxypropanol derivatives and pharmaceutical compositions
IL65493A0 (en) Phenethanolamine derivatives,their preparation and pharmaceutical compositions containing them
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
IT1251979B (it) Derivati diazaciclici